
₹209.00
CQURE-T-1.125 Injection combines Ceftriaxone with Tazobactam to provide enhanced antibiotic activity against resistant bacteria. It is used for complicated bacterial infections of the chest, abdomen, urinary tract, and skin. Hospital administration only.
CQURE-T-1.125 Injection combines Ceftriaxone, a third-generation cephalosporin, with Tazobactam, a beta-lactamase inhibitor. This combination provides a wider spectrum of antibacterial action and is used to treat complicated infections in hospitalised patients. It is given intravenously by a medical professional.
Ceftriaxone destroys bacteria by blocking their cell wall production. Tazobactam inhibits beta-lactamase enzymes that bacteria use to neutralise Ceftriaxone, ensuring the antibiotic stays active. This combination expands the range of bacteria that can be effectively targeted and killed.
(Check with your Doctor if any of these side effects persist or worry you.)
When using this product, you will need a prescription. Administer only by the direction of a clinical master. Do not self-medicate.